404 related articles for article (PubMed ID: 8948665)
1. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
[TBL] [Abstract][Full Text] [Related]
4. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
[TBL] [Abstract][Full Text] [Related]
5. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic differentiation between neoplastic plasma cells in mature B-cell lymphoma vs plasma cell myeloma.
Seegmiller AC; Xu Y; McKenna RW; Karandikar NJ
Am J Clin Pathol; 2007 Feb; 127(2):176-81. PubMed ID: 17210522
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
8. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
[TBL] [Abstract][Full Text] [Related]
9. Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myeloma.
Liu D; Lin P; Hu Y; Zhou Y; Tang G; Powers L; Medeiros LJ; Jorgensen JL; Wang SA
J Clin Pathol; 2012 Sep; 65(9):823-9. PubMed ID: 22685235
[TBL] [Abstract][Full Text] [Related]
10. Purified CD34+ Lin- Thy+ stem cells do not contain clonal myeloma cells.
Gazitt Y; Reading CC; Hoffman R; Wickrema A; Vesole DH; Jagannath S; Condino J; Lee B; Barlogie B; Tricot G
Blood; 1995 Jul; 86(1):381-9. PubMed ID: 7540887
[TBL] [Abstract][Full Text] [Related]
11. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
Pope B; Brown R; Gibson J; Joshua D
Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
[TBL] [Abstract][Full Text] [Related]
12. Detection of myeloma cells in the peripheral blood by flow cytometry.
Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
[TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
Klobusická M; Babusíková O
Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
[TBL] [Abstract][Full Text] [Related]
14. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
[TBL] [Abstract][Full Text] [Related]
15. In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes.
Rasmussen T; Lodahl M; Hancke S; Johnsen HE
Leuk Lymphoma; 2004 Jul; 45(7):1413-7. PubMed ID: 15359642
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous occurrence of myelomonocytic leukemia and multiple myeloma: involvement of common leukemic progenitors and their developmental abnormality of "lineage infidelity".
Akashi K; Harada M; Shibuya T; Fukagawa K; Kimura N; Sagawa K; Yoshikai Y; Teshima T; Kikuchi M; Niho Y
J Cell Physiol; 1991 Sep; 148(3):446-56. PubMed ID: 1655817
[TBL] [Abstract][Full Text] [Related]
17. The increase of CD5LOW+NK cells in patients with multiple myeloma and plasmacytoma.
Ishiyama T; Watanabe K; Fukuchi K; Yajima K; Koike M; Tomoyasu S; Tsuruoka N
Anticancer Res; 1994; 14(2B):725-30. PubMed ID: 7516640
[TBL] [Abstract][Full Text] [Related]
18. Identification of malignant plasma cell precursors in the bone marrow of multiple myeloma.
Caligaris-Cappio F; Bergui L; Tesio L; Pizzolo G; Malavasi F; Chilosi M; Campana D; van Camp B; Janossy G
J Clin Invest; 1985 Sep; 76(3):1243-51. PubMed ID: 2931452
[TBL] [Abstract][Full Text] [Related]
19. The evaluation of minimal residual disease in multiple myeloma by fluorescent molecular beacons in real time PCR of IgH gene rearrangements and correlation with flow cytometry.
Kara IO; Duman BB; Afsar CU
J BUON; 2013; 18(2):442-7. PubMed ID: 23818359
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]